To view the PDF file, sign up for a MySharenet subscription.

AIP - Adcock Ingram Holdings Limited - Update on the MCC resolution to

Release Date: 20/04/2011 17:23
Code(s): AIP
Wrap Text

AIP - Adcock Ingram Holdings Limited - Update on the MCC resolution to withdraw Dextropropoxyphene-Containing Medicines from the South African market Adcock Ingram Holdings Limited (Incorporated in the Republic of South Africa) Registration number 2007/016236/06 Share code: AIP ISIN: ZAE000123436 ("Adcock Ingram") UPDATE ON THE MCC RESOLUTION TO WITHDRAW DEXTROPROPOXYPHENE-CONTAINING MEDICINES FROM THE SOUTH AFRICAN MARKET Adcock Ingram shareholders are referred to the announcements released by Adcock Ingram on 10 December 2010 relating to the recommendation by the Medicines Control Council of the Department of Health ("MCC") to withdraw dextropropoxyphene ("DPP")-containing medicines from the South African market. Shareholders were notified that Adcock Ingram would suspend all promotion and sales of DPP-containing products pending further interaction with the MCC and that Adcock Ingram would work with the MCC to formulate and execute a plan going forward to ensure continued safety of South African patients. The MCC later requested Adcock to prepare for a discussion with the Council on the safety of DPP and measures to be taken by healthcare providers. All the relevant documents were submitted to the MCC. The MCC has considered comments received from Adcock Ingram at a recently held meeting and has resolved to withdraw the registration of all DPP- containing medicines within three months from the date of the notice, being 20 April 2011. Shareholders are advised that Adcock Ingram has a right to appeal the decision made by the MCC in accordance with section 24 of the Medicines and Related Substances Control Act 101 of 1965. The board of directors of Adcock Ingram has resolved to exercise that right and accordingly Adcock Ingram intends formulating and lodging an appeal with the MCC. Shareholders will be informed of further developments as necessary. For queries please contact: Dudu Ndlovu Group Corporate Affairs, Investor Relations and Government Relations Adcock Ingram Tel: +2711 635 0171 Mobile: +27(0) 71 689 9796 For Media queries please contact: Nthabiseng Mofokeng Tel: 011 502 7413 E-mail: nmofokeng@brunswick.co.za Cecilia de Almeida Tel: 011 502 7418 E-mail: cdelameida@brunswick.co.za Midrand 20 April 2011 Sponsor Deutsche Securities (SA) (Proprietary) Limited Date: 20/04/2011 17:23:01 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Share This Story